Durvalumab

Modify Date: 2024-01-02 11:36:54

Durvalumab Structure
Durvalumab structure
Common Name Durvalumab
CAS Number 1428935-60-7 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Durvalumab


Durvalumab (MEDI 4736) is an humanized anti-PD-L1 monoclonal antibody. Durvalumab blocks the interaction of PD-L1 with PD-1 and CD80[1].

 Names

Name Durvalumab

 Durvalumab Biological Activity

Description Durvalumab (MEDI 4736) is an humanized anti-PD-L1 monoclonal antibody. Durvalumab blocks the interaction of PD-L1 with PD-1 and CD80[1].
Related Catalog
References

[1]. Faiena I, et al. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. Drug Des Devel Ther. 2018 Jan 23;12:209-215.

 Chemical & Physical Properties

Storage condition 2-8℃
Top Suppliers:I want be here

No recommended suppliers.


Get all suppliers and price by the below link:

Durvalumab suppliers


Price: ¥2700/1 mg

Reference only. check more Durvalumab price

Hot Compounds More...
Dichloromethane
CAS#:75-09-2
Polyacrylic acid
CAS#:9003-01-4
sodium carbonate
CAS#:497-19-8
Silicon dioxide
CAS#:7631-86-9
Triethanolamine
CAS#:102-71-6
Demeton
CAS#:126-75-0
Water
CAS#:7732-18-5
4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9
Diclofenac sodium
CAS#:15307-79-6
Budesonide
CAS#:51372-29-3